logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9845292 B1

PDFFull Text
Date of Patent:
Dec. 19, 2017

Filed:

Sep. 15, 2014

Selective fkbp51 ligands for treatment of psychiatric disorders

Applicant:

Max-planck-gesellschaft Zur Förderung Der Wissenschaften E.v., Munich, DE;

Inventors:

Steffen Gaali, Munich, DE;

Felix Hausch, Munich, DE;

Alexander Kirschner, Munich, DE;

Xixi Feng, Munich, DE;

Andreas Bracher, Munich, DE;

Gerd Ruehter, Hamburg, DE;

Assignee:

Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Munich, DE;

Attorney:

Knobbe, Martens, Olson & Bear, LLP

Primary Examiner:

Niloofar Rahmani

Int. Cl.
CPC ...
C07D 211/06 (2006.01); C07D 295/00 (2006.01); C07D 207/16 (2006.01); C07D 401/14 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 279/12 (2006.01); C07D 211/60 (2006.01); C07D 211/78 (2006.01); C12N 9/90 (2006.01); G06F 19/16 (2011.01);
U.S. Cl.
CPC ...
C07D 207/16 (2013.01); C07D 211/60 (2013.01); C07D 211/78 (2013.01); C07D 279/12 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 405/12 (2013.01); C12N 9/90 (2013.01); C12Y 502/01008 (2013.01); G06F 19/16 (2013.01); C07B 2200/13 (2013.01);
Abstract

The present invention relates to compounds of the general formula (I) having a selective FKBP51 ligand scaffold, pharmaceutically acceptable salts of these compounds and pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said selective FKBP51 ligand compounds can be used for prophylaxis and/or treatment of psychiatric disorders and neurodegenerative diseases, disorders and conditions.

Find Patent Forward Citations

Gaali, Steffen. (2017). Selective fkbp51 ligands for treatment of psychiatric disorders (U.S. Patent No. 9845292). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9845292

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…